Navigation Links
Novagali Pharma Announces the Launch of Cationorm(R)
Date:4/9/2008

ration of ophthalmic medicines. It is based on the electrostatic attraction that occurs between the droplets of a positively-charged emulsion and the negatively charged cells of the ocular surface, including cornea and conjunctiva.

The commercial launch of Cationorm(R) in Europe and in the United States by the end 2008, where the product complies with the OTC status, is a major event for the development of Novagali Pharma. <>, said Jerome Martinez, CEO of Novagali Pharma.

Cationorm(R) is a medical device available in France since April 2008. The product is unpreserved and packaged in box of 30 sterile single vials.

A propos de Novagali Pharma : http://www.novagali.com

Novagali Pharma is an ophthalmic pharmaceutical company based in the Genopole biocluster in Evry (France) that develops and commercializes innovative products. Thanks to its proprietary technology platforms Novasorb(R) and Eyeject(R), the company has developed a broad pipeline of 7 innovative products addressing main ocular conditions as well as orphan diseases. Most advanced products include Vekacia(R), an orphan product for treatment of vernal keratoconjunctivitis, Cyclokat(R), a product for the treatment of moderate-to-severe dry eye syndrome and Cortiject(R) for the treatment of diabetic retinopathies. Cationorm(R), indicated for dry eye symptoms is commercialized in France since April 2008. Founded in 2000, Novagali Pharma has 50 employees.


'/>"/>
SOURCE Novagali Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2015)... April 30, 2015 According to ... Market by Product (Portable & Non-Portable), Component (Accelerometer, ... Automotive, Chemical, Metal & Mining, & Others), & ... market is expected to reach $1,453.76 Million by ... 71 market data tables and 92 figures spread ...
(Date:4/29/2015)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced its results ... fiscal 2014 year-end financial statements and MD&A have been filed on SEDAR ... , 2014 , 2013 Revenue 3,968 , ... 1,326 , 1,703 , 2,231 , ... 3,377 , 4,562 Ebitda* 92 , 418 ...
(Date:4/29/2015)... , April 29, 2015 Cambrex Corporation (NYSE: ... be released on Friday, May 1, 2015 before the market ... The Company will host a conference call to discuss the ... When: , Friday, May 1, 2015 at ... , 1-888-468-2440 for U.S.1-719-325-2454 for International  Passcode:  7993632 Dial-in ...
(Date:4/29/2015)... April 29, 2015 The leading Regenerative ... that its regenerative stem cell therapy has processed more ... seeking to discover a successful treatment for horses with ... 2003 VetStem signed a worldwide exclusive license for adipose-derived ... the first horse was treated in January 2004. Shortly ...
Breaking Biology Technology:Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 2Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 4Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2
... April 28 Simcere,Pharmaceutical Group (NYSE: SCR ... pharmaceuticals and manufacturer of the patented,anti-cancer biotech product ... Suisse,s 3rd Annual Healthcare Trip, to be held ... and Weihai., Simcere senior management will give ...
... NEW YORK, April 28 Ever been so tired you ... That,s how Holly Jacobson, a nurse,in Clermont, Florida, felt every ... five boys under the age of nine. Nothing a good ... she began experiencing palpitations,breathlessness and fatigue whenever she played with ...
... Corporation,(Nasdaq: ACEL ) today announced that Kuslima Shogen, ... from the company on,or before March 31, 2009. The ... and Alfacell has been terminated., The termination of ... payments from the Company to Ms. Shogen by an ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip 2D-Ribose Helps Energy-Starved Hearts 2Alfacell Announces Retirement of Chief Executive Officer 2Alfacell Announces Retirement of Chief Executive Officer 3Alfacell Announces Retirement of Chief Executive Officer 4
(Date:4/20/2015)... , April 20, 2015 The ... Glenbeigh Records Management (GRM), Ireland,s ... Dubai Islamic Bank. Having built up an impressive track record ... a leading player within the records management sector in ... to double is GCC staffbase and employ a further eight ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... The SARS virus set alarm bells ringing across the world ... of the effectiveness of the treatments used against it has ... was commissioned by the World Health Organization and has been ... is caused by a virus; the main symptoms are pneumonia ...
... executed an exclusive license agreement for a next ... Inc. This innovative DNA-sequencing technology was invented by ... head of DNA Sequencing and Chemical Biology at ... at Columbia University. The fundamentals of this new ...
... diabetics, regenerating heart muscle after it fails, and improving ... list of 10 potential breakthroughs for health in developing ... medicine, according to a study published today in the ... Conducted by University of Toronto researchers (from the McLaughlin ...
Cached Biology News:SARS: No evidence that any of the treatments worked 2SARS: No evidence that any of the treatments worked 3SARS: No evidence that any of the treatments worked 4SARS: No evidence that any of the treatments worked 5Columbia University licenses next-generation DNA sequencing technology 2Replacing insulin is top-ranked breakthrough foreseen for health in developing world 2Replacing insulin is top-ranked breakthrough foreseen for health in developing world 3Replacing insulin is top-ranked breakthrough foreseen for health in developing world 4Replacing insulin is top-ranked breakthrough foreseen for health in developing world 5Replacing insulin is top-ranked breakthrough foreseen for health in developing world 6
... a direct antibiotic-based selection system for recombinant ... survival, eliminating the need for costly color ... close to 100% accuracy in recombinant selection. ... robot colony picking. This cloning kit can ...
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473...
... thermal cycler is a dual-bay expansion for ... operated independently, using a PC. The Dyad ... units (sample-holder, heat-pump assemblies), which hold different ... real-time detector. Peltier heat pumps provide exceptional ...
... PCR plate, Directly compatible with ABI thermal ... for improved sealing characteristics can be ... or cap strips, Certified free of DNase, ... part of Thermo Fisher Scientific, the world ...
Biology Products: